BELITE BIO, INC (BLTE)
About BELITE BIO, INC
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$77.6M
- Total assets
- $780.6M
- Market cap
- $5.7B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.7B
- Shares outstanding
- 38.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 29, 2022
Belite BIO, Inc (BLTE) Stock Price
- Reported a net loss of $77.6M.
- Trading 21% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BELITE BIO, INC.
Write a review
News about BELITE BIO, INC
News & sentiment via Polygon.io
Belite BIO, Inc: frequently asked questions
Is Belite BIO, Inc an American company?
Belite BIO, Inc is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Belite BIO, Inc headquartered?
Belite BIO, Inc is headquartered in San Diego, California, United States.
Is Belite BIO, Inc publicly traded?
Yes — Belite BIO, Inc is a publicly traded company. Its stock trades under the ticker symbol BLTE on the NASDAQ.
What does Belite BIO, Inc do?
Belite BIO, Inc is an American Pharmaceuticals company in the Health & Beauty sector.
